ModifiedUnitedHealthcarePolicy CS032NJ.W

Durable Medical Equipment, Orthotics, Medical Supplies, and Repairs/Replacements (for New Jersey Only)

Policy governing medical necessity, coverage, and documentation requirements for durable medical equipment (DME), orthotics, and related supplies for UnitedHealthcare members in New Jersey. Applies to providers ordering, supplying, or requesting authorization for DME and related items.

Policy Summary

PayerUnitedHealthcare

PolicyDurable Medical Equipment, Orthotics, Medical Supplies, and Repairs/Replacements (for New Jersey Only)

Policy CodePolicy CS032NJ.W

Change TypeMaterial clinical and administrative revisions

Effective DateMay 1, 2026

Next Review DateN/A

Key ActionSubmit medical record documentation including PaCO2 values and device usage data to support prior authorization and continued coverage decisions.

SourceLink

POLICY UPDATE CHANGES

Added reference link to the Medical Policy titled Airway Clearance Devices (for New Jersey Only) and Electrical and Ultrasound Bone Growth Stimulators (for New Jersey Only).

Removed reference link to the Medical Policy titled Lower Extremity Prosthetics (for New Jersey Only), Pediatric Gait Trainers and Standing Systems (for New Jersey Only), and Upper Extremity Prosthetic Devices (for New Jersey Only).

Added language to indicate this policy does not apply to Durable Medical Equipment or supplies used in an outpatient or inpatient facility.

Added instruction to refer to the New Jersey Administrative Code Title 10, Chapter 59, Medical Supplier Manual for medical necessity clinical coverage criteria for Dedicated Speech Generating Devices and Tracheo-Esophageal Voice Devices.

Added language indicating home mechanical ventilators are not medically necessary for individuals with stable COPD with an arterial PaCO2 of less than 52 mm Hg while awake on room air.

Replaced references to 'mechanical ventilators' with 'home mechanical ventilators' and revised related phrasing throughout the policy.

Changed wording for bilevel PAP medical necessity to specify adherent use definitions (at least 4 hours during sleep time on at least 21 to 30 consecutive 24-hour periods) and clarified COPD PaCO2 thresholds while awake on room air.

Revised list of uses for home mechanical ventilators that are not medically necessary and specified HCPCS codes E0465 and E0466 for ventilators used only to deliver CPAP/bilevel.

Removed language indicating ventilators must not be billed using CPAP or bi-level PAP HCPCS codes; updated to state using those codes is incorrect coding but removed the prohibition language.

Added explicit language about medical records documentation requirements to support medical necessity determinations.

Removed language indicating tracheo-esophageal prosthetics and voice aid prosthetics are covered as Durable Medical Equipment.

Updated Clinical Evidence and References sections to reflect current information and archived previous policy version CS032NJ.V.

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

05/01/2026policy revision date

One per birthSingle-user breast pump

5 yearsReasonable Useful Life

PaCO2 <52HMV/BPAP unproven threshold

4 hrs/day on 70% daysUsage threshold for continued BPAP/HMV

Coverage and Medical Necessity Criteria

General DME medical necessity

Durable Medical Equipment (DME) and related supplies are medically necessary when ALL of the following are met:

DME medical necessity general criteria: Item is consistent with the state definition of DME; meets the plan's definition of Medically Necessary (federal, state, or contractual requirements); is ordered by an authorized practitioner (physician, or NP/CNS/PA acting within scope of practice); and is not otherwise excluded from coverage.

Ventilators / Bilevel PAP

Home mechanical ventilators and bilevel PAP medical necessity / not medically necessary statements:

Medically necessary ventilator indications: Home mechanical ventilators (HCPCS E0465, E0466) are considered medically necessary for treatment of neuromuscular diseases, thoracic restrictive diseases, and chronic respiratory failure consequent to COPD in certain clinical scenarios per InterQual criteria.

Refer to InterQual Client Defined criteria link in policy.

Not medically necessary uses: Home mechanical ventilators are not medically necessary when used only in bilevel PAP mode (HCPCS E0470/E0471), used only to deliver continuous or intermittent PAP (HCPCS E0465/E0466), or used for non–life‑threatening conditions where interruption of support would not quickly lead to serious harm or death.

Specific PaCO2 thresholds for COPD described elsewhere in policy.

Bilevel PAP unproven use limitations

Limitations on bilevel PAP:

Unproven bilevel PAP: Bilevel PAP (with or without backup rate) is considered unproven and not medically necessary for central sleep apnea (CSA) and obstructive sleep apnea (OSA) when adherent use is less than 4 hours during sleep time on at least 21–30 consecutive days. Bilevel PAP is also unproven and not medically necessary for individuals with COPD with an arterial PaCO2 < 52 mm Hg while awake on room air (even when certain asleep PaCO2 thresholds are observed).<4 hours/night on 21–30 consecutive days; awake PaCO2 < 52 mm Hg

Revised adherence and PaCO2 language in 2026 update.

Breast pump coverage

Breast pump coverage:

Single-user pump: One single‑user double electric or manual breast pump (HCPCS E0603 or E0602) is provided per birth event at any time during pregnancy and throughout the postpartum period, and may continue for the duration of breastfeeding as defined by the individual.one per birth event

HCPCS E0603, E0602.

Multi-user pump: Multi‑user, hospital‑grade electric breast pump (HCPCS E0604) is covered upon recommendation from a qualified healthcare professional without regard to provision of a single‑user pump; a letter of medical necessity from a lactation consultant or other healthcare provider may be required. Specifications for multi‑user pumps are enumerated in policy.

HCPCS E0604; LON may be required.

Repair, Replacement, and Upgrade — General Criteria

General DME repair, replacement, and upgrade coverage when member has a DME benefit and criteria met:

Member has DME benefit: Member must have an applicable DME benefit for repair, replacement, or upgrade to be covered.

Repair necessity: Repairs, including replacement of essential accessories (hoses, tubes, mouthpieces, etc.), are covered when necessary to make the DME serviceable.

Replacement necessity: Replacement is covered for same or similar equipment that is beyond its Reasonable Useful Life (RUL) and irreparable. Unless otherwise stated, RUL = 5 years. RUL does not apply to supply items.RUL = 5 years

Requests for exceptions are based on member‑specific benefit and medical necessity.

Upgrade necessity:

HMV and BPAP coverage considerations for COPD

Coverage stance for home mechanical ventilators and bilevel positive airway pressure (BPAP) in individuals with COPD:

Not supported when PaCO2 < 52 mm Hg: Home mechanical ventilators (HMVs) and BPAP are considered unproven for individuals with chronic stable COPD when awake arterial PaCO2 is less than 52 mm Hg on room air.awake PaCO2 < 52 mm Hg

Evidence supporting use in hypercapnic COPD: Systematic reviews and RCTs report benefits (reduced mortality, fewer hospital admissions, improved PaO2/PaCO2 and symptoms) primarily in patients with higher baseline PaCO2 (eg, ≥55 mm Hg) or those who achieve substantial PaCO2 reduction with therapy.baseline PaCO2 ≥ 55 mm Hg associated with greater mortality benefit

Limitations and need for further research: Evidence quality varies (trial heterogeneity, risk of bias, inconsistent quality‑of‑life outcomes) and larger multicenter RCTs are warranted to validate findings.

PAP therapy definitions

PAP therapy scoring definition used for evaluation:

Hypopnea definition (AASM 2023): Hypopnea = respiratory event ≥10 seconds with ≥30% airflow reduction and ≥3% oxygen desaturation from baseline or associated with an arousal.duration ≥10s; airflow reduction ≥30%; desaturation ≥3%

AASM Scoring Manual, 2023.

NIPPV coverage criteria for COPD

Covered when ALL of the following are met (per CHEST/CMS and Canadian Thoracic Society guidance):

Eligibility for long-term NIPPV in COPD: Patient has COPD with chronic hypercapnic respiratory failure defined as arterial PaCO2 ≥ 52 mm Hg, or sleep apnea is not the predominant cause of hypercapnia, or hypercapnia or stable COPD is present at least 2 weeks after hospitalization for COPD exacerbation.PaCO2 ≥ 52 mm Hg or timing ≥ 2 weeks after hospitalization

CHEST and Canadian Thoracic Society guidance.

Acceptable evaluation outcomes within 6 months of starting NIPPV: Evaluation within 6 months must show normalization of PaCO2 OR stabilization of rising PaCO2 OR a 20% reduction in PaCO2 from baseline OR improvement in symptoms associated with chronic hypercapnia.one of the listed outcomes

CHEST coverage criteria.

Device-related indications:

Medical necessity and guideline-based criteria

Guideline-based coverage considerations and UnitedHealthcare medical necessity clarifications present in this portion of the policy include:

Guideline recommendations for long-term NIV in COPD: Professional society guidance suggests considering long‑term NIV for stable severe COPD patients with chronic hypercapnic respiratory failure (PaCO2 ≥ 52 mm Hg) and for patients with persistent hypercapnia after an acute exacerbation (persistent PaCO2 ≥ 52 mm Hg at least 2 weeks after hospitalization); recommendations are generally conditional/weak.PaCO2 ≥ 52 mm Hg

Canadian Thoracic Society, CHEST/CMS guidance.

UnitedHealthcare medical necessity exclusion for stable COPD: UnitedHealthcare considers home mechanical ventilators not medically necessary for individuals with stable COPD with arterial PaCO2 < 52 mm Hg while awake on room air.PaCO2 < 52 mm Hg while awake on room air

Policy language added 05/01/2026.

Bilevel PAP adherence requirement:

Any device that is fully implanted into the body is not covered as Durable Medical Equipment (DME). If such a device is covered, it is considered part of the surgical/medical‑surgical benefit rather than the DME benefit.

Contact lenses or scleral shells used to treat an injury or disease (for example, corneal abrasion, keratoconus, or severe dry eye) are not considered DME. Coverage, if any, should be determined under applicable federal, state, or contractual therapeutic service provisions.

Any device, appliance, pump, machine, stimulator, or monitor that is fully implanted into the body is excluded from the DME benefit. Implantable components are considered part of the medical‑surgical/surgical benefit; external components (for example, external cochlear implant parts) may remain under DME as specified by benefit rules.

Coverage limitations and exclusions in this policy follow applicable federal, state, or contractual requirements. Providers should consult those governing documents to determine coverage for specific items or services.

When summarizing guideline evidence for COPD and long‑term noninvasive ventilation (NIV), referenced guidelines excluded studies that primarily involved sleep apnea or obesity‑related hypoventilation. This distinction informed COPD‑specific recommendations in the cited guidance.

This policy does not apply to Durable Medical Equipment or supplies used in an outpatient or inpatient facility; place‑of‑service provisions in federal, state, and contractual documents govern those settings.

Home mechanical ventilators that are used only in bilevel PAP mode, used only to deliver continuous or intermittent PAP, or used for non‑life‑threatening indications are not medically necessary as DME when those limited uses are the sole function of the device.

Because evidence is insufficient in certain populations, home mechanical ventilators (HMVs) and BPAP are considered unproven (not sufficiently supported) for individuals with stable COPD when the awake arterial PaCO2 is less than 52 mm Hg on room air.

Bilevel PAP (with or without backup rate) is considered unproven and not medically necessary for central sleep apnea (CSA) or obstructive sleep apnea (OSA) when adherent use is less than 4 hours during sleep time on at least 21 to 30 consecutive 24‑hour periods.

UnitedHealthcare considers home mechanical ventilators not medically necessary for individuals with stable COPD who have an arterial PaCO2 of less than 52 mm Hg while awake on room air. This PaCO2 threshold is used to distinguish patients for whom long‑term ventilatory support may be indicated from those for whom it is not supported by current evidence.

Item-Specific Medical Necessity Rules

Breast pumps

Single-user pump (detailed): One single‑user double electric or manual breast pump (HCPCS E0603 or E0602) per birth event; breast pump supplies HCPCS A4281–A4286 and K1005 are covered. Hands‑free bras (A9900) and other supportive items may be covered to support individuals with disabilities.one per birth event

See multi‑user specifications for E0604.

Home mechanical ventilators

HMV equipment indications: Home mechanical ventilators (HCPCS E0465, E0466) are considered medically necessary for neuromuscular disease, thoracic restrictive disease, and chronic respiratory failure consequent to COPD in scenarios defined by InterQual; HMVs used only to deliver CPAP/BPAP or in non‑life‑threatening situations are not medically necessary.

Refer to InterQual criteria link in policy; PaCO2 thresholds apply for COPD.

Codes, RUL, and Key Thresholds

Breast pump and suppliesHCPCSCovered

E0603	Single-user double electric breast pump
E0602	Manual breast pump
E0604	Multi-User, Hospital Grade Electrical Breast Pump
A4281	Breast pump supply
A4282	Breast pump supply
A4283	Breast pump supply
A4284	Breast pump supply
A4285	Breast pump supply
A4286	Breast pump supply
K1005	Breast pump supply

1–10 of 11

1/2

Home mechanical ventilators and bilevel PAPHCPCS

E0465	Home mechanical ventilator, specified
E0466	Home mechanical ventilator, specified
E0470	Bilevel PAP device
E0471	Bilevel PAP device

Cranial remolding and protective helmetsHCPCSCovered

S1040	Cranial molding helmet (cranial remolding orthosis)
A8000	Protective helmet (not a cranial remolding device)
A8001	Protective helmet
A8002	Protective helmet
A8003	Protective helmet
A8004	Protective helmet

Implanted device benefit clarificationmixed

misc	External components of cochlear implant considered under DME benefit (implantable components are part of the medical-surgical benefit)

HCPCS codes discussedHCPCS

E0465	Trilogy-style ventilator (example) / home mechanical ventilator (referenced)
E0466	Trilogy-style ventilator (example) / home mechanical ventilator (referenced)
E0601	CPAP device (noted in coding discussion)
E0470	Bi-level PAP, single patient use (noted in coding discussion)
E0471	Bi-level PAP, two or more pressure settings, one-way valving (noted in coding discussion)
E0472	Bi-level PAP, with backup rate (noted in coding discussion)

Reasonable Useful Lifetime (RUL) — 5 years

Reasonable Useful Lifetime (RUL)5 years (standard RUL for DME, computed from delivery to the member)

RUL applicationApplies to durable equipment replacements unless otherwise stated in policy or contract

ExemptionsRUL does not apply to supply items necessary for effective use of the DME

PaCO2 / Hypopnea definition — Hypopnea definition and PaCO2 threshold context

Hypopnea definition (PAP scoring)Event ≥10 seconds with ≥30% airflow reduction plus ≥3% oxygen desaturation from baseline or associated arousal (AASM Scoring Manual, 2023)

Prior Authorization, Documentation, and Operational Steps

Prior Authorization

Prior Authorization Required / Documentation Expectations

Prior authorization may be required and requests for home mechanical ventilators, bilevel PAP (BPAP) devices, and certain DME (for example, multi-user hospital-grade breast pumps) will be evaluated against the plan's clinical criteria. Requests for replacement or upgrades are treated as new services and require the same documentation and prior authorization as initial requests. Medical record documentation must fully support medical necessity and may be requested to adjudicate coverage decisions.

Prior authorization: may be required for Home Mechanical Ventilators, BPAP devices, and multi-user hospital-grade breast pumps (E0604); a letter of medical necessity from a lactation consultant or other provider may be requested for multi-user pumps.
Replacement/Upgrade: Equipment upgrades or replacements are treated as new requests and require physician documentation showing change in condition; DME RUL generally = 5 years unless otherwise stated.
Documentation required: legible medical record with relevant history, physical exam, diagnostic test results, and any InterQual or CMS/CHEST criteria evidence as applicable.

Rental, Purchase, and Replacement Rules

Item	Rule
Single‑user breast pump (HCPCS E0603 or E0602)
One double electric or manual breast pump per birth event; provided at any time during pregnancy and throughout postpartum for duration of breastfeeding.
Multi‑user, hospital grade breast pump (HCPCS E0604)
Multi‑user pumps are covered (purchase or rental) upon recommendation; a letter of medical necessity may be required.

Context	Responsibility / Rule
Rented equipment
Vendors/manufacturers are responsible for repairs, replacements, and maintenance for rented equipment.
Purchased equipment under warranty
Vendors/manufacturers are responsible for repairs, replacements, and maintenance for purchased equipment covered by warranty.

Aspect	Coverage distinction / implication
CHEST/CMS eligibility criteria for NIPPV in COPD
Patients with COPD eligible for NIPPV if PaCO2 ≥ 52 mm Hg, sleep apnea not predominant cause of hypercapnia, or persistent hypercapnia ≥2 weeks after hospitalization; evaluation within 6 months must show PaCO2 improvement/stabilization or symptom improvement.
Devices with HMV features (alarms, internal battery, prolonged support) vs BPAP
An HMV is indicated when patient requires FiO2 ≥36% (≈4 L nasal), ventilatory support >8 hours/day, or needs alarms/internal battery; such features may imply HMV rather than BPAP for coverage decisions.
Adherence and PaCO2 thresholds affecting coverage
Bilevel PAP is considered unproven/not medically necessary for COPD when awake PaCO2 < 52 mm Hg; bilevel PAP adherence requirements revised to define 'adherent use' (see policy history).

HCPCS / Device	Purchase vs Rental / Usage note
E0465, E0466 — Home mechanical ventilators
Policy notes E0465 and E0466 when ventilators are used only to deliver CPAP/bilevel; rental vs purchase guidance for HMVs referenced in policy fragment (full rule likely elsewhere).
BPAP devices (e.g., E0470, E0471)
Bilevel PAP devices distinguished from HMVs; devices used only in bilevel PAP mode or only to deliver continuous/intermittent PAP are described as not medically necessary in specified non‑life‑threatening situations.

Replacement and Reasonable Useful Life

General DME — RUL 5 years

General RUL for DME5 years is the standard Reasonable Useful Lifetime for durable medical equipment

ComputationRUL is computed from date of delivery to the member, not the equipment manufacture date

Exceptions and suppliesRUL does not apply to supply items necessary for effective use of the DME; exceptions handled per member benefit and medical necessity

DME (general) — Every 5 years (Reasonable Useful Life)

Replacement intervalReplacement of durable equipment is permitted when item is beyond its Reasonable Useful Life (5 years)

Case-by-case exceptionsRequests for exceptions to the 5‑year RUL are reviewed per member benefit plan and medical necessity

Medical Record and Documentation Requirements

Documentation Required

Submit supporting medical records when requested

Submit supporting medical records upon request for review; records must include relevant history, physical exam, and diagnostic test results that support the requested service's medical necessity.

Ensure clinical documentation is comprehensive and readily producible upon request.

Documentation Required

Provide full new-request documentation for upgrade requests; supplies exempt from RUL

When requesting upgrades, provide the same documentation required for a new equipment request; note that supply items are exempt from the Reasonable Useful Life rule.

Attach physician documentation showing clinical change to justify upgrade.
Do not apply RUL to necessary supply items.

Documentation Required

Include PaCO2, timing after exacerbation, 6-month follow-up, and device usage data

Items Not Covered / Exclusions

Fully implanted devices are excluded from DME and should be processed under the surgical/medical‑surgical benefit. Similarly, ventilators that are functioning only as bilevel PAP devices (or to deliver only PAP) are not supported as DME when those limited uses are the sole indication for the device.

Reiterating exclusions: devices fully implanted in the body are not DME and are part of the surgical benefit. Home mechanical ventilators that are used solely to provide bilevel PAP or continuous/intermittent PAP are noted as not medically necessary as DME in applicable scenarios.

Implantable components are excluded from the DME benefit and must be billed as part of the surgical/medical‑surgical benefit; external components of implants (for example, cochlear external parts) may fall under DME per benefit rules.

BPAP (with or without backup rate) is considered unproven and therefore not medically necessary for CSA or OSA when patient adherence is below the stated minimal usage—specifically, when use is 4 hours per night on the defined consecutive‑day period (21–30 consecutive days as the adherence window).

Tracheo‑esophageal prosthetics and voice aid prosthetics are no longer indicated as covered DME in this policy version; consult the policy history and benefit documents for applicable coverage changes.

Background and Scope

Durable Medical Equipment (DME) consists of durable, nonexpendable items that are primarily used for a medical purpose and are generally not useful in the absence of disease or disability. Medical necessity determinations follow applicable federal, state, and contractual definitions.

Definitions and Key Terms

Durable Medical Equipment (DME) definition

Definition (DME)Durable Medical Equipment (DME): items primarily and customarily prescribed to serve a medical purpose, not generally useful absent disease, and capable of withstanding repeated use

ExamplesExamples include hospital beds, oxygen equipment, wheelchairs, walkers, and suction equipment

Regulatory noteFederal, state, or contractual definitions supersede policy definitions where applicable

Reasonable Useful Lifetime (RUL) — Standard time for reasonable use of DME set at five years

Standard RULReasonable Useful Lifetime (RUL) for DME is set at five years

Computation basisComputed from delivery to the member (CMS, 2021)

Policy Revision History

2026-05-01policy_revisionLatest

Multiple revisions including addition of NJ-specific related policy links, clarification that the policy does not apply to DME/supplies used in outpatient or inpatient facilities, and addition of a UnitedHealthcare medical necessity exclusion for home mechanical ventilators in stable COPD with awake PaCO2 < 52 mm Hg.

2026-05-01terminology_update

Replaced references to 'mechanical ventilators' with 'home mechanical ventilators' and revised related phrasing throughout the policy.

2026-05-01clinical_threshold_change

Policy Summary

PayerUnitedHealthcare

PolicyDurable Medical Equipment, Orthotics, Medical Supplies, and Repairs/Replacements (for New Jersey Only)

Policy CodePolicy CS032NJ.W

Change TypeMaterial clinical and administrative revisions

Effective DateMay 1, 2026

Next Review DateN/A

Key ActionSubmit medical record documentation including PaCO2 values and device usage data to support prior authorization and continued coverage decisions.

SourceLink

On This Page

Upgrades require physician documentation demonstrating a change in the member's condition that necessitates different equipment; upgrade requests are treated as new service requests and require equivalent documentation.

General operational criteria: Routine wear that renders equipment non‑functional while the member still requires it is eligible for coverage; vendors/manufacturers are responsible for repairs/replacements for rented equipment or under warranty; pediatric DME must allow room for growth (minimum +2 inches seat width and +3 inches seat depth).pediatric +2 in width, +3 in depth

An HMV is indicated if the patient requires FiO2 ≥ 36% (≈4 L nasal), requires ventilatory support > 8 hours/day, or requires alarms/internal battery features of an HMV.

FiO2 ≥ 36% or >8 hours/day or HMV alarms/battery needed

Continued use requirement: Continued coverage of BPAP or HMV requires device usage of at least 4 hours/day on at least 70% of days each month.≥4 hours/day on ≥70% of days

Bilevel PAP is considered unproven and not medically necessary when adherent use is less than 4 hours during sleep time on at least 21–30 consecutive 24‑hour periods (adherent use definition revised in 2026).

<4 hours/night on 21–30 consecutive days

Policy revision clarified adherence criteria.

DME medical necessity criteria (general)

Member benefit required: Member must have an applicable DME benefit for repair/replacement/upgrade coverage to apply.

Repair covered when serviceable needed: Repairs, including replacement of essential accessories, are covered when necessary to make the device serviceable.

Replacement when beyond RUL: Replacement is covered when equipment is beyond its Reasonable Useful Life (default 5 years) and irreparable; supply items are exempt from RUL.RUL = 5 years

Upgrade documentation: Upgrades require physician documentation of changed clinical condition and are treated as new service requests requiring the same documentation as initial equipment requests.

HMV / BPAP clinical necessity considerations

COPD PaCO2 consideration: HMVs and BPAP are considered unproven for individuals with chronic stable COPD when awake PaCO2 < 52 mm Hg on room air.awake PaCO2 < 52 mm Hg

Evidence indicates benefit in hypercapnic COPD: Systematic reviews and RCTs demonstrated reductions in mortality, hospital admissions, and improvements in PaO2/PaCO2 and symptoms mainly in patients with higher baseline PaCO2 (eg, ≥55 mm Hg) or those achieving substantial PaCO2 reductions with therapy.baseline PaCO2 ≥ 55 mm Hg

DME medical necessity for long-term NIV

Long-term NIV eligibility: Consider long‑term NIV for patients with COPD and chronic hypercapnic respiratory failure (PaCO2 ≥ 52 mm Hg) or persistent hypercapnia at least 2 weeks after hospitalization for COPD exacerbation; evaluation within 6 months must demonstrate PaCO2 normalization, stabilization, ≥20% reduction from baseline, or symptom improvement.PaCO2 ≥ 52 mm Hg; evaluation outcomes within 6 months

CHEST/CMS and Canadian Thoracic Society guidance.

DME medical necessity criteria

Hypopnea and adherence thresholds: Hypopnea defined per AASM: ≥10 seconds with ≥30% airflow reduction and ≥3% desaturation or arousal. Bilevel PAP adherence is defined as at least 4 hours/night on 21–30 consecutive days for coverage/adherence assessments. PaCO2 thresholds of ≥52 mm Hg support consideration for long‑term NIV; PaCO2 < 52 mm Hg indicates ventilator not medically necessary in stable COPD.hypopnea: ≥10s/≥30%/≥3%; adherence: ≥4 hours/night on 21–30 days; PaCO2 threshold ≥52 mm Hg

Policy revisions clarified adherence and PaCO2 thresholds in 2026.

PaCO2 contextPaCO2 thresholds are used in determining appropriateness of ventilatory support in COPD; awake PaCO2 values are emphasized for coverage decisions

Use in policyHypopnea definition applied for PAP therapy evaluation and scoring referenced in coverage criteria

PaCO2 threshold — ≥ 52 mm Hg

PaCO2 thresholdArterial PaCO2 ≥ 52 mm Hg is the primary threshold referenced for considering long-term ventilatory support in COPD

Policy exclusion contextHMVs and BPAP are considered unproven/not medically necessary for chronic stable COPD when awake PaCO2 < 52 mm Hg on room air

Guideline supportCHEST and Canadian Thoracic Society guidance reference PaCO2 ≥ 52 mm Hg for considering long-term NIV

NIV minimum daily usage for coverage continuation — ≥ 4 hours/day on ≥ 70% of days each month

Minimum daily usage for continued coverageAt least 4 hours per day on at least 70% of days each month is required for continued coverage of BPAP/HMV

Documentation requirementDevice usage data must be documented and may be requested to demonstrate compliance with the usage threshold

Denial riskFailure to meet the usage criteria may risk denial of continued coverage

PaCO2 threshold for considering long-term NIV — ≥ 52 mm Hg (≈7.0 kPa)

Consider long-term NIV whenPersistent arterial PaCO2 ≥ 52 mm Hg (≈7.0 kPa) in severe/stable COPD or persistent hypercapnia ≥2 weeks after hospitalization

Guideline alignmentCHEST, Canadian Thoracic Society, and Swiss guidance reference PaCO2 thresholds ≈52 mm Hg (≈7.0 kPa) for considering NIV

Required follow-upEvaluation within 6 months must show PaCO2 normalization, stabilization, ≥20% reduction, or symptom improvement to continue therapy

Adherent use for bilevel PAP — ≥ 4 hours/night on 21–30 consecutive days

Adherent use definition (bilevel PAP)Use of at least 4 hours during sleep time on 21–30 consecutive 24‑hour periods constitutes adherent use for bilevel PAP

Implication for coverageBilevel PAP considered unproven/not medically necessary when adherent use is less than this threshold

Relation to other usage rulesThis adherent-use definition is distinct from the continued-use monthly requirement (4 hours/day on ≥70% days)

Documentation Required

NIPPV Eligibility and Required Follow-up

Noninvasive positive pressure ventilation (NIPPV) eligibility for COPD-related chronic respiratory failure follows CHEST/CMS-aligned criteria: patients with COPD and chronic hypercapnia (PaCO2 ≥ 52 mm Hg on arterial blood gas) may be eligible; eligibility also requires that sleep apnea is not the predominant cause of hypercapnia or that hypercapnia/clinical status is present ≥ 2 weeks after a hospitalization for COPD exacerbation. An evaluation within 6 months of starting NIPPV is required and must demonstrate improvement or stabilization in PaCO2 or related symptoms.

Eligibility thresholds: PaCO2 ≥ 52 mm Hg; sleep apnea not predominant cause documented; or hypercapnia present ≥ 2 weeks post-hospitalization.
Follow-up evaluation within 6 months must show normalization or stabilization of PaCO2, ≥20% reduction in PaCO2, or improvement in symptoms associated with chronic hypercapnia.
Clinical documentation: arterial blood gas results with timing relative to exacerbation (≥ 2 weeks), documentation that sleep apnea is not predominant cause when applicable, and follow-up test results and clinical notes.

Denial Risk

Ventilator and Bilevel PAP Exclusions

Home mechanical ventilators and BPAP devices have specific exclusions. Ventilators are not considered medically necessary when used only in bilevel PAP mode or solely to deliver continuous or intermittent PAP, or when used for non–life-threatening conditions where interruption of support would not rapidly lead to serious harm. BPAP is considered unproven/not medically necessary in certain CSA/OSA and some COPD scenarios per InterQual and evidence statements.

Ventilator exclusions: devices used only in bilevel PAP mode (E0470, E0471) or only to deliver continuous/intermittent PAP (E0465, E0466) are not medically necessary.
BPAP exclusions/unproven: BPAP (with or without backup rate) is unproven/not medically necessary for CSA/OSA when adherence is <4 hours/night for 21–30 consecutive days, and for COPD patients with awake PaCO2 <52 mm Hg in certain scenarios.
Coverage decisions reference InterQual criteria for specific medically necessary scenarios.

Denial Risk

Usage Compliance Requirement

Continued coverage of BPAP devices or home mechanical ventilators requires objective usage compliance. Failure to meet the usage threshold may result in discontinuation of coverage.

Usage requirement: at least 4 hours per day on at least 70% of days each month.
Noncompliance: failure to meet usage criteria may lead to discontinuation of therapy coverage and re-evaluation of medical necessity.

Note

Modality Sequencing and Adherence Support (Not Step Therapy)

This policy section is not organized as a step therapy program. Decisions about escalation from CPAP to BPAP or ventilator support are driven by clinical criteria and documented response to therapy rather than predefined step-therapy mandates.

Modality sequencing: CPAP (with or without supplemental oxygen) is commonly trialed first for central sleep apnea and many OSA cases; CPAP was effective in a substantial portion of patients in cited studies.
Adherence support before escalation: provide education, heated humidification, appropriate mask selection, troubleshooting for leaks, and follow-up (e.g., at 4 weeks) to improve PAP adherence prior to considering escalation to BPAP or other modalities.
Telemonitoring or behavioral interventions may be used during the initial period to optimize adherence.

Billing Rule

Replacement, Repair, and Upgrade Operational Rules

Providers should expect requests for replacement or upgrades to be reviewed with the same documentation standards as new equipment requests. Repair may be required instead of replacement if equipment is reparable and not beyond its reasonable useful life.

Reasonable Useful Life (RUL): generally 5 years for DME unless otherwise specified; RUL does not apply to necessary supply items.
Replacement criteria: equipment must be beyond RUL and irreparable; exceptions considered case-by-case per benefit plan and medical necessity.
Upgrade documentation: physician must document change in condition necessitating upgrade; treated as new service with full supporting medical records.

Supply exemptionSupply items are exempt from the RUL; they may be replaced as clinically necessary

Replacement — Not specified in this fragment (placeholder)

Replacement detailsReplacement guidance not specified in this policy fragment; replacements generally require equipment to be beyond RUL and irreparable

Review basisReplacement approvals are based on member benefit terms and clinical documentation

Supply itemsSupply items are not subject to RUL and are not included in this replacement fragment

For NIPPV and HMV requests, include clinical and device usage documentation: PaCO2 values, timing relative to COPD exacerbation (≥2 weeks after hospitalization if applicable), and follow-up evaluations within 6 months showing specified PaCO2 improvements or symptom benefit; include device usage data for continued coverage.

Document arterial PaCO2 and timing after exacerbation, and include 6-month follow-up outcomes.
Provide device adherence data to meet continuation thresholds (≥4 hrs/day on ≥70% of days).

Documentation Required

Provide comprehensive history, exam, and test results to support medical necessity

Submit relevant history, physical exam findings, and diagnostic test results to support medical necessity; documentation must be legible and available upon request to evaluate whether clinical criteria are met.

Ensure medical records comprehensively document the clinical rationale for DME.
Make records available promptly when requested for coverage review.

ApplicationApplies to durable equipment replacements unless otherwise stated by policy or contract; supplies exempt

hypopnea — definition used in PAP scoring

Hypopnea (PAP scoring)An abnormal respiratory event ≥10 seconds with ≥30% airflow reduction plus ≥3% oxygen desaturation from baseline or associated with an arousal (AASM Scoring Manual, 2023)

Use caseApplied for evaluation and scoring of PAP therapy in policy criteria

Threshold componentsDuration ≥10s; airflow reduction ≥30%; desaturation ≥3% or arousal

Chronic hypercapnic respiratory failure in COPD (often defined in cited guidelines as PaCO2 ≥ 52 mm Hg)

Hypercapnic COPD definitionChronic hypercapnic respiratory failure in COPD is often defined in guidelines as arterial PaCO2 ≥ 52 mm Hg

Evidence baseRCTs and guideline reviews report benefits of NIV primarily in patients with higher baseline PaCO2 (eg, ≥55 mm Hg) or persistent hypercapnia

Policy implicationPaCO2 thresholds guide eligibility for long-term NIPPV per CHEST/CMS and Canadian guidance

Chronic hypercapnic respiratory failure — elevated arterial PaCO2 thresholds referenced (≥52 mm Hg or >7.0 kPa)

Elevated PaCO2 thresholdChronic hypercapnic respiratory failure referenced with arterial PaCO2 thresholds of ≥52 mm Hg (or >7.0 kPa / >52.5 mm Hg in some guidance)

Timing considerationPersistent hypercapnia ≥2 weeks after hospitalization for COPD exacerbation supports consideration of long-term NIV

Guideline nuanceSome guidelines suggest targeting PaCO2 <6.5 kPa (≈50 mm Hg) or a ≥20% reduction when titrating NIV

Adherent use (bilevel PAP) — at least 4 hours during sleep time on at least 21 to 30 consecutive 24-hour periods

Adherent use for bilevel PAPAdherent use is defined as at least 4 hours during sleep time on at least 21 to 30 consecutive 24‑hour periods

Coverage consequenceBilevel PAP is considered unproven and not medically necessary when adherence is below this standard

Relation to other adherence rulesThis 21–30 day consecutive period standard is distinct from the monthly continued-use requirement (4 hours/day on ≥70% of days)

Revised bilevel PAP medical necessity wording to specify adherent use definitions and clarified COPD PaCO2 thresholds while awake on room air.

2026-05-01coding_clarification

Revised list of uses for home mechanical ventilators that are not medically necessary and specified HCPCS codes E0465 and E0466 for ventilators used only to deliver CPAP/bilevel; removed prior prohibition language about billing with CPAP or bi-level PAP HCPCS codes.

2026-05-01operational_update

Added explicit language about medical records documentation requirements to support medical necessity determinations and availability upon request.

2026-05-01benefit_change

Removed language indicating tracheo-esophageal prosthetics and voice aid prosthetics are covered as Durable Medical Equipment.